Table 5.
Modality | Use |
---|---|
CT | Large infarcts/haemorrhage, established small vessel disease, other pathologies, limited application |
MRI | Imaging of choice for assessment of cognitive impairment54 |
T1 and T2 MRI | Highly sensitive to old and new infarcts, estimation of white matter disease load, other pathologies (e.g. malignancies, cerebral oedema) |
T2* MRI | Blood and blood products (e.g. haemorrhages), micro-haemorrhages, haemosiderin deposition, amyloid angiopathies |
DWI MRI | Extremely sensitive to early ischaemic changes (recent infarcts including micro-infarcts), integrity of fibre tracts, extensively used for tractography assessing the structural integrity of connecting white matter tracts |
1H-MRS | Measurement of neuronal damage, inflammation, gliosis, differentiation between pathology and normal aging |
1H-MRS, proton magnetic resonance spectroscopy; CT, computed tomography; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.